See If You Qualify

For Caregivers & Loved Ones

How you can help

If your loved one has been diagnosed with lymphoma, their journey shouldn’t be a lonely one.

Learning that you have lymphoma is never easy. It can spur a range of emotions for people when they are initially diagnosed, and caring for a loved one with lymphoma means you are experiencing cancer alongside them. It is natural to feel tired, or worried, or even overwhelmed. For those facing refractory or relapsed lymphoma, the experience can bring back a range of emotions they felt when they were first diagnosed. These emotions might be no easier to cope with the second time around, even if your loved one is aware that there are options available.

As a loved one, you are a partner, a friend, a health aid, an advocate, and you may be highly involved in the decision-making process when it comes to potential options. If your loved one has lymphoma, they may be able to take part in a research study.

Here’s how you can help:

Share & Educate

Share this website with your loved one so they can learn more about these research studies.

Share This

Download Study Guide

Download a study guide with more information on one of the EPCORE program studies that you can share with your loved one.

Download the EPCORE NHL-5 Study Guide
Download the EPCORE PEDS-1 Study Guide
Download the EPCORE NHL-6 Study Guide
Download the EPCORE FL-1 Study Guide
Download the EPCORE DLBCL-2 Study Guide
Download the EPCORE FL-2 Study Guide
Download the EPCORE DLBCL-4 Study Guide

Speak to a Doctor

Encourage your loved one to speak with their doctor about clinical research study participation. You can download a discussion guide to help foster the conversation between your loved one and their physician.

Download Discussion Guide

Share & Educate

Share this website with your loved one so they can learn more about these research studies.

Share This

Encourage Contact

Our team is happy to answer questions from you or your loved one. Encourage your loved one to contact our nurses to ask any questions they may have and see if they may qualify to participate in a study.

[(999) 999-9999]

Download Study Guide

Download a study guide with more information on one of the EPCORE program studies that you can share with your loved one.

Download the EPCORE NHL-5 Study Guide
Download the EPCORE PEDS-1 Study Guide
Download the EPCORE NHL-6 Study Guide
Download the EPCORE FL-1 Study Guide
Download the EPCORE DLBCL-2 Study Guide

Speak to a Doctor

Encourage your loved one to speak with their doctor about clinical research study participation. You can download a discussion guide to help foster the conversation between your loved one and their physician.

Download Discussion Guide

Great—let’s get you back to the homepage.

Back to Home

Quick Facts on Non-Hodgkin Lymphoma2

  • Non-Hodgkin lymphoma (NHL) affects the lymphatic system, which includes a network of vessels, nodes, and ducts that help to maintain body fluid levels and remove cellular waste. It is more common than HL.
  • There are two broad categories of NHLs:
  • B-cell lymphomas (which account for about 85% of all NHLs)
  • T-cell lymphomas (which account for about 15% of all NHLs)
  • In terms of growth, NHLs are broken down into two categories:
  • Indolent = slow-growing
  • Aggressive = fast-growing
  • There are more than 90 types of NHLs overall. Although NHLs have traits in common, they may have different growth patterns, different appearances under a microscope, and different responses to treatment.
  • Symptoms include swollen lymph nodes, fever, night sweats, fatigue, and weight loss.

Quick Facts on Mantle Cell Lymphoma (MCL)12

  • Mantle cell lymphoma is a rare form of B-cell non-Hodgkin lymphoma (NHL). It is considered a B-cell lymphoma because it affects the B-lymphocytes. Lymphocytes help your body fight infections.
  • This rare condition affects only about 1 in 200,000 people each year.
  • Within lymph nodes, there are compartments called lymphatic nodules. There is a ring of small lymphocytes that surround the center of each nodule—this is the mantle zone. With MCL, your body overproduces lymphocytes in the mantle zone.
  • MCL is an aggressive NHL, which means that it progresses quickly. It typically affects older adults between 60 and 70 years old.
  • The most common symptoms of MCL include swollen lymph nodes, fatigue, night sweats, fever, and unexplained weight loss.
  • MCL is typically diagnosed through a combination of physical examination, blood tests, imaging studies, and a lymph node biopsy.

Quick Facts on Follicular Lymphoma

  • Follicular lymphoma is a type of cancer that affects white blood cells called B-lymphocytes. Lymphocytes help your body fight infections.
  • Follicular lymphoma is a non-Hodgkin lymphoma (NHL). It is also a B-cell lymphoma because it affects the B-lymphocytes.
  • Follicular lymphoma accounts for 20–40% of all NHLs in Western Europe and the United States.7
  • Follicular lymphoma is an indolent NHL, which means that it progresses slowly. People with follicular lymphoma may not notice any obvious symptoms of it.
  • Symptoms include swollen lymph nodes (especially in the part of the body where the lymphoma starts to grow), fever, night sweats, fatigue, and weight loss.8
  • Incidence of follicular lymphoma increases with age, and it is the most common form of indolent NHL.9

Quick Facts on Diffuse Large B-Cell Lymphoma

  • Diffuse large B-cell lymphoma (DLBCL) is the most common of all NHLs worldwide.4
  • DLBCL is considered an aggressive or fast-growing NHL. It is also a B-cell lymphoma because it affects white blood cells called B-lymphocytes. Lymphocytes help your body fight infections.
  • Although DLBCL can affect children, and is one of the most common NHL subtypes in children,5 people over the age of 60 are most commonly affected by DLBCL.4
  • For many with DLBCL, the first symptom is rapid swelling in the neck, underarms, or groin. The swelling is caused by enlarged lymph nodes.6
  • Treatment will depend on the subtype of DLBCL. For example, there are subtypes that mostly occur in younger patients and affect the chest cavity, while there are other subtypes that only affect the brain.6